1. Fludarabine phosphate

   • Gladys Rodriguez

   Review Pages: 75 - 92

2. Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR

   • Mariangela Mariani
   • Laura Capolongo
   • William T. Beck

   Preclinical Studies Pages: 93 - 97

3. Evaluation of the methemoglobinemia associated with Sulofenur

   • David C. Molthrop Jr.
   • Richard H. Wheeler
   • Josef T. Prchal

   Preclinical Studies Pages: 99 - 102

4. Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome)

   • Perry Guaglianone
   • Kenneth Chan
   • Franco Muggia

   Phase I Studies Pages: 103 - 110

5. Weekly gemcitabine in advanced or metastatic solid tumors

   • Camillo F. Pollera
   • Anna Ceribelli
   • Federico Calabresi

   Phase I Studies Pages: 111 - 119

6. Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors

   • Vicram Gupta
   • E. Brad Thompson
   • Jean Beckord

   Phase II Studies Pages: 121 - 128

7. Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer

   • Joshua O. Atiba
   • Stephanie J. Green
   • Mark Davidner

   Phase II Studies Pages: 129 - 132

8. Phase II trial of intravenous melphalan in advanced colorectal carcinoma

   • Dennis F. Moore Jr.
   • Richard Pazdur
   • James L. Abbruzzese

   Phase II Studies Pages: 133 - 136

9. A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma

   • Jordan Berlin
   • A. Christie King
   • George Wilding

   Phase II Studies Pages: 137 - 141

10. Phase II trial of topotecan in patients with advanced renal cell carcinoma

    • Teresa Murray Law
    • David H. Ilson
    • Robert J. Motzer

    Phase II Studies Pages: 143 - 145

11. Phase II evaluation of merbarone in renal cell carcinoma

    • Robert C. Flanigan
    • Joseph H. Saiers
    • E. David Crawford

    Phase II Studies Pages: 147 - 149

12. Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885

    • Alex Y. Chang
    • Z. Nora Tu
    • Donald L. Trump

    Phase II Studies Pages: 151 - 153

13. Phase II trial of trimetrexate in untreated advanced gastric carcinoma

    • Alexander Hantel
    • Catherine M. Tangen
    • Theodore Pollock

    Phase II Studies Pages: 155 - 157

14. Phase II trial of piroxantrone in gastric carcinoma

    • Alexander Hantel
    • Catherine Tangen
    • John S. Macdonald

    Phase II Studies Pages: 159 - 161

15. Phase II study of fludarabine phosphate for gastric adenocarcinoma

    • Lary J. Kilton
    • Julia B. Ashenhurst
    • Al. B. Benson III

    Phase II Studies Pages: 163 - 166